Loomis Sayles & Co. L P Purchases 86,012 Shares of Bath & Body Works, Inc. $BBWI

Loomis Sayles & Co. L P lifted its position in Bath & Body Works, Inc. (NYSE:BBWI) by 12.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 790,542 shares of the company’s stock after purchasing an additional 86,012 shares during the quarter. Loomis Sayles & Co. L P owned 0.37% of Bath & Body Works worth $23,685,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of BBWI. Stonehage Fleming Financial Services Holdings Ltd acquired a new position in shares of Bath & Body Works in the 2nd quarter valued at $33,000. SVB Wealth LLC acquired a new stake in shares of Bath & Body Works during the 1st quarter valued at about $35,000. Geneos Wealth Management Inc. increased its stake in Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after acquiring an additional 801 shares during the period. Parallel Advisors LLC raised its position in Bath & Body Works by 63.3% in the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock worth $37,000 after purchasing an additional 481 shares in the last quarter. Finally, Parkside Financial Bank & Trust raised its position in Bath & Body Works by 24.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock worth $55,000 after purchasing an additional 364 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have weighed in on BBWI. UBS Group lowered their price objective on Bath & Body Works from $32.00 to $17.00 and set a “neutral” rating on the stock in a research note on Friday, November 21st. JPMorgan Chase & Co. decreased their price target on Bath & Body Works from $26.00 to $15.00 and set a “neutral” rating on the stock in a research note on Thursday, November 20th. Zacks Research cut Bath & Body Works from a “hold” rating to a “strong sell” rating in a research report on Monday, November 24th. New Street Research set a $26.00 price objective on Bath & Body Works in a research note on Monday, November 24th. Finally, Raymond James Financial restated a “market perform” rating on shares of Bath & Body Works in a research note on Wednesday, November 12th. Six analysts have rated the stock with a Buy rating, twelve have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $25.17.

Bath & Body Works Price Performance

BBWI stock opened at $17.50 on Friday. The business has a fifty day moving average price of $23.69 and a 200 day moving average price of $27.60. Bath & Body Works, Inc. has a fifty-two week low of $14.27 and a fifty-two week high of $41.87. The stock has a market capitalization of $3.58 billion, a price-to-earnings ratio of 5.19, a P/E/G ratio of 0.86 and a beta of 1.53.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Thursday, November 20th. The company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.40 by ($0.05). Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The business had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the previous year, the company posted $0.49 EPS. Bath & Body Works’s revenue for the quarter was down 1.0% on a year-over-year basis. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. On average, equities analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Friday, November 21st will be given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 4.6%. The ex-dividend date is Friday, November 21st. Bath & Body Works’s dividend payout ratio (DPR) is presently 24.62%.

Insider Activity at Bath & Body Works

In related news, Director Lucy Brady purchased 3,470 shares of the firm’s stock in a transaction dated Friday, November 21st. The shares were acquired at an average cost of $14.40 per share, with a total value of $49,968.00. Following the completion of the purchase, the director directly owned 17,482 shares of the company’s stock, valued at $251,740.80. This trade represents a 24.76% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Francis Hondal acquired 3,343 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The stock was bought at an average price of $14.99 per share, with a total value of $50,111.57. Following the transaction, the director directly owned 21,554 shares in the company, valued at $323,094.46. The trade was a 18.36% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders have bought 33,513 shares of company stock worth $500,442. 0.26% of the stock is owned by insiders.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.